BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8789435)

  • 21. [Detection of PAX3/PAX7-FKHR fusion transcript in rhabdomyosarcoma by one-step RT-PCR].
    Chang B; Yin BM; Li F; Li XX; Lu TC; Hu WH; Jiang JF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1336-8. PubMed ID: 12930690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
    Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG
    Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal and rearranged PAX3 expression in human rhabdomyosarcoma.
    Frascella E; Toffolatti L; Rosolen A
    Cancer Genet Cytogenet; 1998 Apr; 102(2):104-9. PubMed ID: 9546061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.
    Laé M; Ahn EH; Mercado GE; Chuai S; Edgar M; Pawel BR; Olshen A; Barr FG; Ladanyi M
    J Pathol; 2007 Jun; 212(2):143-51. PubMed ID: 17471488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma.
    Bennicelli JL; Edwards RH; Barr FG
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5455-9. PubMed ID: 8643596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression.
    Tomescu O; Xia SJ; Strezlecki D; Bennicelli JL; Ginsberg J; Pawel B; Barr FG
    Lab Invest; 2004 Aug; 84(8):1060-70. PubMed ID: 15184910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
    Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma.
    Galili N; Davis RJ; Fredericks WJ; Mukhopadhyay S; Rauscher FJ; Emanuel BS; Rovera G; Barr FG
    Nat Genet; 1993 Nov; 5(3):230-5. PubMed ID: 8275086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells.
    Massuda ES; Dunphy EJ; Redman RA; Schreiber JJ; Nauta LE; Barr FG; Maxwell IH; Cripe TP
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14701-6. PubMed ID: 9405676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases.
    Gil-Benso R; López-Ginés C; Carda C; López-Guerrero JA; Ferrer J; Pellín-Pérez A; Llombart-Bosch A
    Cancer Genet Cytogenet; 2003 Jul; 144(2):125-33. PubMed ID: 12850375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fusions involving paired box and fork head family transcription factors in the pediatric cancer alveolar rhabdomyosarcoma.
    Barr FG
    Curr Top Microbiol Immunol; 1997; 220():113-29. PubMed ID: 9103678
    [No Abstract]   [Full Text] [Related]  

  • 32. Structural analysis of PAX3 genomic rearrangements in alveolar rhabdomyosarcoma.
    Barr FG; Nauta LE; Hollows JC
    Cancer Genet Cytogenet; 1998 Apr; 102(1):32-9. PubMed ID: 9530337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.
    Keller C; Hansen MS; Coffin CM; Capecchi MR
    Genes Dev; 2004 Nov; 18(21):2608-13. PubMed ID: 15520281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural characterization of the FKHR gene and its rearrangement in alveolar rhabdomyosarcoma.
    Davis RJ; Bennicelli JL; Macina RA; Nycum LM; Biegel JA; Barr FG
    Hum Mol Genet; 1995 Dec; 4(12):2355-62. PubMed ID: 8634710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PAX3-FKHR induces morphological change and enhances cellular proliferation and invasion in rhabdomyosarcoma.
    Anderson J; Ramsay A; Gould S; Pritchard-Jones K
    Am J Pathol; 2001 Sep; 159(3):1089-96. PubMed ID: 11549601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene.
    Khan J; Bittner ML; Saal LH; Teichmann U; Azorsa DO; Gooden GC; Pavan WJ; Trent JM; Meltzer PS
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13264-9. PubMed ID: 10557309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of fusion gene PAX3/PAX7-FKHR and chromosomal aberration in rhabdomyosarcoma].
    Gao H; Ou YL; Zhang KR; Zhang ZB; Wang WL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):42-7. PubMed ID: 17285543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX--FKHR fusion genes and AChR-gamma in Chinese patients with rhabdomyosarcoma: diagnosis using formalin-fixed archival tissues.
    Chang B; Pang LJ; Qi Y; Liu CX; Cao Y; Li HA; Hu WH; Jiang JF; Zhang WJ; Li F
    Int J Surg Pathol; 2009 Feb; 17(1):6-15. PubMed ID: 18988640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma.
    Rodeberg DA; Nuss RA; Heppelmann CJ; Celis E
    Cancer Immunol Immunother; 2005 Jun; 54(6):526-34. PubMed ID: 15838707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of chimeric paired box transcription factors in the pathogenesis of pediatric rhabdomysarcoma.
    Barr FG
    Cancer Res; 1999 Apr; 59(7 Suppl):1711s-1715s. PubMed ID: 10197585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.